Sector pending / Hospital and Medical Service PlansUpdated 2026-05-10 22:07 UTC

BCBA/HAPV3 stock hub

BCBA/HAPV3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCBA/HAPV3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.6T

Buenos Aires Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BCBA/HAPV3

In the news

Latest news · BCBA/HAPV3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.3

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-0.3

P25 n/aP50 n/aP75 n/a

ROIC2.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCBA/HAPV3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

186

Groups with data

Currency

BRL

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Brazil
Country code	AR
Employees	66,000
Employees Change	2,000%
Employees Change Percent	3.03
Enterprise value	ARS 3.8T
Exchange	Buenos Aires Stock Exchange
Financial currency	BRL
First seen	2026-05-10
Industry	Hospital and Medical Service Plans
Last refreshed	2026-05-10
Market cap	ARS 1.6T
Price	ARS 3,630
Price currency	ARS
Rev Per Employee	126,073,386.74x
Sic	6324
Symbol	bcba/HAPV3
Website	https://ri.hapvida.com.br

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.34%
EV Earnings	-102.4x
EV/EBIT	8.51x
EV/EBITDA	4.55x
EV/FCF	10.99x
EV/Sales	0.43x
FCF yield	21.83%
Forward P/E	14.25x
P/B ratio	0.13x
P/S ratio	0.19x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5%
EBITDA Margin	8.49%
FCF margin	4.18%
Gross margin	11.79%
Gross Profit	ARS 981.2B
Gross Profit Growth	12.81%
Gross Profit Growth Q	-26.21%
Gross Profit Growth5 Y	2.16%
Net Income	ARS -37.4B
Pretax Margin	-0.74%
Profit Margin	-0.45%
Profit Per Employee	ARS -565,931
ROA	1.35
Roa5y	0.56
ROCE	2.37
ROE	-0.29
Roe5y	-0.68
ROIC	2.81
Roic5y	1.25

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	671.78%
FCF Growth	-39.92%
FCF Growth3 Y	43.36%
FCF Growth5 Y	3.87%
OCF Growth	-23.9%
OCF Growth Q	-49.19%
OCF Growth3 Y	28.52%
OCF Growth5 Y	9.25%
Revenue Growth	9.21x
Revenue Growth Q	6.51x
Revenue Growth3 Y	9.87x
Revenue Growth5 Y	29.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.43
Assets	ARS 19T
Cash	ARS 2.1T
Current Assets	ARS 3T
Current Liabilities	ARS 1.6T
Debt	ARS 4.1T
Debt EBITDA	ARS 5.31
Debt Equity	ARS 0.33
Debt FCF	ARS 11.89
Equity	ARS 12.7T
Interest Coverage	0.58
Liabilities	ARS 6.3T
Long Term Assets	ARS 16T
Long Term Liabilities	ARS 4.8T
Net Cash	ARS -2.1T
Net Cash By Market Cap	ARS -130
Net Debt EBITDA	ARS 2.92
Net Debt Equity	ARS 0.16
Net Debt FCF	ARS 5.94
Tangible Book Value	ARS -145.6B
Tangible Book Value Per Share	ARS -307

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.9
Inventory Turnover	76.39
Net Working Capital	ARS -323.1B
Quick ratio	1.72
Working Capital	ARS 1.3T
Working Capital Turnover	ARS 1,540

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.51%
Dividend Growth Years	1%
Dividend per share	ARS 0
Dividend Years	1
Last Dividend	ARS 7,868

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	670.7%
200-day SMA	6,093.5
50-day SMA	3,190.8
50-day SMA vs 200-day SMA	50under200
All Time High	11,800
All Time High Change	-69.24%
All Time High Date	2025-09-18
All Time Low	385
All Time Low Change	842.86%
All Time Low Date	2024-12-30
ATR	281.3
Ch YTD	-12.48
High	3,837.5
High52	11,800
High52 Date	2025-09-18
High52ch	-69.24%
Low	3,630
Low52	470
Low52 Date	2025-05-12
Low52ch	672.34%
Ma50ch	13.76%
Price vs 200-day SMA	-40.43%
RSI	52.99
RSI Monthly	49.7
RSI Weekly	45.63
Sharpe ratio	0.97x
Sortino ratio	20.61
Total Return	1.51%
Tr YTD	-12.48
Tr1m	18.72%
Tr1w	3.79%
Tr3m	6.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ARS 416.4B
Operating Income Growth	193.5
Operating Income Growth5 Y	4.52
Operating margin	5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	232,547,650%
Net Borrowing	-162,078,615,177.3
Shares Insiders	3.79%
Shares Institutions	34.63%
Shares Qo Q	-4.05%
Shares Yo Y	-1.51%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 341.9B
Average Volume	10,054.45x
Bv Per Share	26,781.5
CAPEX	ARS -195.8B
Ch1m	18.72
Ch1w	3.79
Ch1y	670.7
Ch3m	6.61
Ch6m	-57.82
Change	-4.91%
Change From Open	-0.48
Close	3,817.5
Days Gap	-4.45
Depreciation Amortization	313,312,807,263.7
Dollar Volume	3,161,730
Earnings Date	2026-05-11
EBIT	ARS 416.4B
EBITDA	ARS 706.5B
EPS	ARS -74.44
F Score	5
FCF	ARS 348B
FCF EV Yield	9.1x
Financing CF	-853,831,373,310
Fiscal Year End	December
Founded	1,979
Goodwill	12,853,787,788,085.6
Income Tax	ARS -24.2B
Investing CF	383,554,848,148
Is Primary Listing	0
Last Earnings Date	2026-03-18
Last Report Date	2025-12-31
Ma150	5,002.8
Ma150ch	-27.44%
Ma20	3,734.6
Ma20ch	-2.8%
Net CF	73,437,203,595
Next Earnings Date	2026-05-11
Open	3,647.5
P FCF Ratio	4.58
P OCF Ratio	2.93
Payment Date	2025-07-03
Position In Range	0
Ppne	1,844,788,864,801.6
Price Date	2026-05-08
Price EBITDA	ARS 2.26
Relative Volume	0.07x
Revenue	8,320,843,525,044x
SBC By Revenue	0.07x
Share Based Comp	6,021,149,237
Tax By Revenue	-0.29x
Tr6m	-57.82%
Volume	871
Z Score	1.01

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BCBA/HAPV3 pay a dividend?

Capital-return profile for this ticker.

Performance

BCBA/HAPV3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BCBA/HAPV3?

Insider, institutional, and short-interest positioning.

Institutional ownership

+34.6%

Share of float held by funds and institutions

Insider ownership

+3.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.5%

Negative means the company is buying back shares.

Technical

BCBA/HAPV3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.0

Neutral momentum band

Price vs 200-day MA

-40.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.97

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCBA/HAPV3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bcba/HAPV3 stock rating?

bcba/HAPV3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bcba/HAPV3 analysis?

The full report lives at /stocks/bcba/HAPV3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bcba/HAPV3?

The latest report frames bcba/HAPV3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bcba/HAPV3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.